NCT02534870View on ClinicalTrials.gov

Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

ABT-450/r/ABT-267

Tablet

DRUG

ABT-333

Tablet

Trial Locations (1)

200031

Site Reference ID/Investigator# 137655, Shanghai

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY